Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency (vol 128, pg 45, 2016)

被引：0
|
作者：
Cicalese, M. P.
Ferrua, F.
Castagnaro, L.
机构：
来源：
BLOOD | 2017年 / 129卷 / 24期
关键词：
D O I：
10.1182/blood-2017-05-782862
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3271 / 3271
页数：1
相关论文
共 38 条
  • [31] Efficacy and safety of sofosbuvir-based antiviral therapy to treat hepatitis C virus infection after kidney transplantation (vol 16, pg 1474, 2016)
    Kamar, N.
    Marion, O.
    Rostaing, L.
    Cointault, O.
    Ribes, D.
    Lavayssiere, L.
    Esposito, L.
    Del Bello, A.
    Metivier, S.
    Barange, K.
    Izopet, J.
    Alric, L.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2016, 16 (08) : 2499 - 2499
  • [32] Evidence for Long-term Efficacy and Safety of Gene Therapy for Wiskott-Aldrich Syndrome in Preclinical Models (vol 17, pg 1073, 2009)
    Marangoni, Francesco
    Bosticardo, Marita
    Charrier, Sabine
    Draghici, Elena
    Locci, Michela
    Scaramuzza, Samantha
    Panaroni, Cristina
    Ponzoni, Maurilio
    Sanvito, Francesca
    Doglioni, Claudio
    Liabeuf, Marie
    Gjata, Bernard
    Montus, Marie
    Siminovitch, Katherine
    Aiuti, Alessandro
    Naldini, Luigi
    Dupre, Loic
    Roncarolo, Maria Grazia
    Galy, Anne
    Villa, Anna
    MOLECULAR THERAPY, 2009, 17 (07) : 1300 - 1300
  • [33] Hematopoietic Stem Cell Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immunodeficiency Leads to Long-Term Immunological Recovery and Metabolic Correction (vol 5, 168er1, 2013)
    Gaspar, H. B.
    Cooray, S.
    Gilmour, K. C.
    Parsley, K. L.
    Zhang, F.
    Adams, S.
    Bjorkegren, E.
    Bayford, J.
    Brown, L.
    Davies, E. G.
    Veys, P.
    Fairbanks, L.
    Bordon, V.
    Petropoulou, T.
    Kinnon, C.
    Thrasher, A. J.
    SCIENCE TRANSLATIONAL MEDICINE, 2013, 5 (168)
  • [34] Efficacy and Safety of Adeno-Associated Virus-Based Clinical Gene Therapy for Hemophilia: A Systematic Review and Meta-Analysis (vol 35, pg 93, 2024)
    Han
    HUMAN GENE THERAPY, 2024,
  • [35] Efficacy and Safety Study of Olmesartan Medoxomil, Amlodipine, and Hydrochlorothiazide Combination Therapy in Patients with Hypertension Not Controlled with Olmesartan Medoxomil and Hydrochlorothiazide Combination Therapy: Results of a Randomized, Double-Blind, Multicenter Trial (vol 16, pg 129, 2016)
    Sohn, Il Suk
    Kim, Chong-Jin
    Oh, Byung-Hee
    Hong, Taek-Jong
    Park, Chang-Gyu
    Kim, Byung-Soo
    Chung, Woo-Baek
    AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS, 2016, 16 (02) : 139 - 139
  • [36] Efficacy and Safety of Baricitinib in Japanese Patients with Active Rheumatoid Arthritis Receiving Background Methotrexate Therapy: A 12-week, Double-blind, Randomized Placebo-controlled Study (vol 43, pg 504, 2016)
    Tanaka, Y.
    Emoto, K.
    Cai, Z.
    Aoki, T.
    Schlichting, D.
    Rooney, T.
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (05) : 999 - 999
  • [37] AN OPEN-LABEL, DOSE ESCALATION STUDY TO ASSESS THE SAFETY AND EFFICACY OF AAV1-LPLS447X GENE THERAPY WITH ALIPOGENE TIPARVOVEC (AMT-011) FOR PATIENTS WITH SEVERE HYPERTRIGLYCERIDEMIA DUE TO LIPOPROTEIN LIPASE DEFICIENCY (LPLD)
    Gaudet, D.
    Brisson, D.
    Methot, J.
    van Deventer, S.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [38] "OAB-005: Update of safety and efficacy of Isatuximab short-duration fixed-volume infusion plus Bortezomib, Lenalidomide, and Dexamethasone combined therapy for NDMM ineligible/with no immediate intent for ASCT" [vol 21, pg S3, 2021]
    Ocio, Enrique M.
    Perrot, Aurore
    Bories, Pierre
    San-Miguel, Jesus F.
    Blau, Igor W.
    Karlin, Lionel
    Martinez-Lopez, Joaquin
    Ponisch, Wolfram
    Bringhen, Sara
    Marcatti, Magda
    Mateos, Maria-Victoria
    Rodriguez-Otero, Paula
    LeRoux, Nadia
    Dong, Yvonne
    Macc, Sandrine
    Fitzmaurice, Thomas
    Moreau, Philippe
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (06): : 425 - 425
1234